Fatal agranulocytosis: the use of olanzapine in a patient with schizophrenia and myelodysplasia.

Neutropenia and agranulocytosis are risks known to occur with phenothiazines and clozapine. The mechanisms responsible for these conditions currently remain unclear. To our knowledge, no case of fatal agranulocytosis as a result of olanzapine treatment was reported in the literature.